April 27, 2016
  • Veterans Study Warns of Kidney Risks in
    Long-Term PPI Use

    Literally millions of Americans use proton pump inhibitors—whether by prescription or OTC—and some have done so for an extended period of time. Find out why a new study suggests that might be ill-advised and how pharmacists might counsel patients.

  • Weight-Loss Medications Underused Despite
    Guideline Recommendations

    With the high rate of obesity in the United States and the availability of FDA-approved therapies, new research finds it surprising that pharmacists aren’t filling more prescriptions for weight-loss medications. Learn which products were most often prescribed and how closely patients adhered to those regimens.

  • Blood Eosinophil Rates Help Predict Exacerbation Risk After ICS Withdrawal
    Widely accepted guidelines generally recommend the use of inhaled corticosteroids only in COPD patients with severe to very severe lung function impairment and/or at high risk of exacerbations, primarily because of serious side effects. A new study offers advice on better selecting the subset of patients who will benefit. Here are the details.
  • Androgen-Deprivation Users Need to Understand Mental Health Risks

    Androgen-deprivation therapy (ADT) might have value in limiting progression in patients with localized prostate cancer, but the benefit apparently comes at a cost. A new study finds that ADT significantly increases the risk of depression in men who use it. Here is more information on how pharmacists should caution patients.


Connect With U.S. Pharmacist
USP Google AppUSP Itunes App